Genetic Mechanisms of Chronic Myeloid Leukemia Blastic Transformation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Mechanisms of Chronic Myeloid Leukemia Blastic Transformation
Authors
Keywords
-
Journal
Current Hematologic Malignancy Reports
Volume 7, Issue 2, Pages 87-93
Publisher
Springer Nature
Online
2012-02-11
DOI
10.1007/s11899-012-0114-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
- (2011) A. Fabarius et al. BLOOD
- CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
- (2011) H. Makishima et al. BLOOD
- The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile
- (2011) C. A. Eide et al. CANCER RESEARCH
- BCR-ABL1 Kinase: Hunting an Elusive Target with New Weapons
- (2011) Tomasz Skorski CHEMISTRY & BIOLOGY
- Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia
- (2011) C Roche-Lestienne et al. LEUKEMIA
- A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
- (2011) V Grossmann et al. LEUKEMIA
- Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors
- (2011) Ronald L. Paquette et al. Cancer Genetics
- New Drugs for Chronic Myelogenous Leukemia
- (2011) Fabio P. S. Santos et al. Current Hematologic Malignancy Reports
- BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP
- (2010) Daniela Salles et al. CARCINOGENESIS
- Chronic myeloid leukemia: mechanisms of blastic transformation
- (2010) Danilo Perrotti et al. JOURNAL OF CLINICAL INVESTIGATION
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
- (2010) Kazuhito Naka et al. NATURE
- Technical aspects and clinical applications of measuringBCR-ABL1transcripts number in chronic myeloid leukemia
- (2009) Letizia Foroni et al. AMERICAN JOURNAL OF HEMATOLOGY
- SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations
- (2009) D. Nowak et al. BLOOD
- The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia
- (2009) Lars Klemm et al. CANCER CELL
- Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia
- (2009) T. D. Kim et al. HAEMATOLOGICA
- Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment
- (2009) C Haferlach et al. LEUKEMIA
- Cell Cycle Regulation by Oncogenic Tyrosine Kinases in Myeloid Neoplasias: From Molecular Redox Mechanisms to Health Implications
- (2008) Margret S. Rodrigues et al. ANTIOXIDANTS & REDOX SIGNALING
- Up-regulation of WRN and DNA ligase III in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks
- (2008) A. Sallmyr et al. BLOOD
- RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance
- (2008) C. Roche-Lestienne et al. BLOOD
- BCR/ABL Inhibits Mismatch Repair to Protect from Apoptosis and Induce Point Mutations
- (2008) T. Stoklosa et al. CANCER RESEARCH
- BCR/ABL and Other Kinases from Chronic Myeloproliferative Disorders Stimulate Single-Strand Annealing, an Unfaithful DNA Double-Strand Break Repair
- (2008) K. Cramer et al. CANCER RESEARCH
- Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells
- (2008) H. Konig et al. CANCER RESEARCH
- Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL
- (2008) C. G. Mullighan et al. GENES & DEVELOPMENT
- Cryptic and partial deletions ofPRDM16andRUNX1without t(1;21)(p36;q22) and/orRUNX1-PRDM16fusion in a case of progressive chronic myeloid leukemia: A complex chromosomal rearrangement of underestimated frequency in disease progression?
- (2008) Lauréline Deluche et al. GENES CHROMOSOMES & CANCER
- BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold
- (2008) J Dierov et al. LEUKEMIA
- BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress
- (2008) M Koptyra et al. LEUKEMIA
- Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis
- (2008) J S Khorashad et al. LEUKEMIA
- BCR/ABL, DNA damage and DNA repair: Implications for new treatment concepts
- (2008) Tomasz Skorski LEUKEMIA & LYMPHOMA
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
- (2008) Charles G. Mullighan et al. NATURE
- Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia
- (2008) S.-J. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now